ATE169001T1 - Substituierte spiro-azaringen als tachykinine rezeptor antagonisten - Google Patents
Substituierte spiro-azaringen als tachykinine rezeptor antagonistenInfo
- Publication number
- ATE169001T1 ATE169001T1 AT94907866T AT94907866T ATE169001T1 AT E169001 T1 ATE169001 T1 AT E169001T1 AT 94907866 T AT94907866 T AT 94907866T AT 94907866 T AT94907866 T AT 94907866T AT E169001 T1 ATE169001 T1 AT E169001T1
- Authority
- AT
- Austria
- Prior art keywords
- pct
- receptor antagonists
- tachykinin receptor
- azaringene
- substituted spiro
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/20—Spiro-condensed ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pulmonology (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US1023393A | 1993-01-28 | 1993-01-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE169001T1 true ATE169001T1 (de) | 1998-08-15 |
Family
ID=21744688
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT94907866T ATE169001T1 (de) | 1993-01-28 | 1994-01-25 | Substituierte spiro-azaringen als tachykinine rezeptor antagonisten |
Country Status (10)
Country | Link |
---|---|
US (1) | US5869496A (de) |
EP (1) | EP0681571B1 (de) |
JP (1) | JPH08505880A (de) |
AT (1) | ATE169001T1 (de) |
AU (1) | AU693087B2 (de) |
CA (1) | CA2154569A1 (de) |
DE (1) | DE69412067T2 (de) |
DK (1) | DK0681571T3 (de) |
ES (1) | ES2119174T3 (de) |
WO (1) | WO1994017045A1 (de) |
Families Citing this family (51)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5439914A (en) * | 1994-02-18 | 1995-08-08 | Merck & Co., Inc. | Spirocycles |
US5434158A (en) * | 1994-04-26 | 1995-07-18 | Merck & Co., Inc. | Spiro-substituted azacycles as neurokinin-3 antagonists |
TW432061B (en) * | 1994-08-09 | 2001-05-01 | Pfizer Res & Dev | Lactams |
GB9421709D0 (en) * | 1994-10-27 | 1994-12-14 | Zeneca Ltd | Therapeutic compounds |
WO1997019084A1 (en) * | 1995-11-23 | 1997-05-29 | Merck Sharp & Dohme Limited | Spiro-piperidine derivatives and their use as tachykinin antagonists |
RU2135494C1 (ru) | 1995-12-01 | 1999-08-27 | Санкио Компани Лимитед | Гетероциклические соединения и композиция на их основе, проявляющая антагонистическое действие в отношении рецепторов тахикинина |
GB9603136D0 (en) * | 1996-02-15 | 1996-04-17 | Merck Sharp & Dohme | Therapeutic agents |
GB9603137D0 (en) * | 1996-02-15 | 1996-04-17 | Merck Sharp & Dohme | Therapeutic agents |
US5756743A (en) * | 1996-04-10 | 1998-05-26 | Hoechst Marion Roussel Inc. | Spiro cyclopent b!indole-piperidines! |
KR20000022060A (ko) * | 1996-06-21 | 2000-04-25 | 더블유. 지. 콜 | 스피로-피페리딘 유도체 및 치료제로서의 이의 용도 |
US5945428A (en) * | 1996-11-01 | 1999-08-31 | Schering Corporation | Substituted oximes, hydrazones and olefins as neurokinin antagonists |
US5962462A (en) * | 1996-12-13 | 1999-10-05 | Merck & Co., Inc. | Spiro-substituted azacycles as modulators of chemokine receptor activity |
US5783579A (en) * | 1996-12-20 | 1998-07-21 | Schering Corporation | Spiro-substituted azacyclic-substituted piperazino derivatives as neurokinin antagonists |
GB9711114D0 (en) | 1997-05-29 | 1997-07-23 | Merck Sharp & Dohme | Therapeutic agents |
US6013644A (en) * | 1997-12-12 | 2000-01-11 | Merck & Co., Inc. | Spiro-substituted azacycles as modulators of chemokine receptor activity |
ID25477A (id) * | 1998-01-23 | 2000-10-05 | Sankyo Co | Turunan-turunan spiropiperidin |
CA2376076A1 (en) * | 1999-06-07 | 2000-12-14 | Warner-Lambert Company | Tricyclic analgesics |
EP1426375A3 (de) * | 1999-07-21 | 2004-12-15 | AstraZeneca AB | Analgetische Spiroindolderivate |
DE60229736D1 (de) | 2001-04-18 | 2008-12-18 | Euro Celtique Sa | Spiroinden- und spiroindan-verbindungen |
SE0202133D0 (sv) * | 2002-07-08 | 2002-07-08 | Astrazeneca Ab | Novel compounds |
CA2503720A1 (en) * | 2002-10-30 | 2004-05-21 | Merck & Co., Inc. | Gamma-aminoamide modulators of chemokine receptor activity |
WO2004092179A1 (ja) * | 2003-04-14 | 2004-10-28 | Nippon Soda Co. Ltd. | スピロ誘導体、製造法および抗酸化薬 |
TW200524868A (en) | 2003-07-31 | 2005-08-01 | Zeria Pharm Co Ltd | Benzylamine derivatives |
US7091211B2 (en) * | 2003-07-31 | 2006-08-15 | Merck & Co., Inc. | Cyclopentyl modulators of chemokine receptor activity |
NZ546834A (en) * | 2003-10-01 | 2010-03-26 | Adolor Corp | Spirocyclic heterocyclic derivatives and methods of their use |
GB0328906D0 (en) | 2003-12-12 | 2004-01-14 | Syngenta Participations Ag | Chemical compounds |
US7288563B2 (en) * | 2004-02-19 | 2007-10-30 | Bristol-Myers Squibb Company | Substituted bicycloalkylamine derivatives as modulators of chemokine receptor activity |
US7230022B2 (en) * | 2004-02-19 | 2007-06-12 | Bristol-Myers Squibb Company | Substituted fused bicyclic amines as modulators of chemokine receptor activity |
US7381738B2 (en) | 2004-02-19 | 2008-06-03 | Bristol-Myers Squibb Company | Substituted bicycloalkylamine derivatives as modulators of chemokine receptor activity |
US7479496B2 (en) * | 2004-02-19 | 2009-01-20 | Bristol-Myers Squibb Company | Substituted spiro azabicyclics as modulators of chemokine receptor activity |
US7864913B2 (en) * | 2004-02-19 | 2011-01-04 | Kabushiki Kaisha Toshiba | Fast reactor having reflector control system and neutron reflector thereof |
AU2005214274A1 (en) | 2004-02-25 | 2005-09-01 | Sankyo Company, Limited | Indanol derivative |
JO2676B1 (en) * | 2004-04-06 | 2012-06-17 | جانسين فارماسوتيكا ان. في | Derivatives of second-aza-spiro- (5,4) -dikan and their use as antihistamines |
JO2527B1 (en) * | 2004-04-06 | 2010-03-17 | شركة جانسين فارماسوتيكا ان. في | Derivatives of second-aza-Spiro- (5,5) -andecan and their use as antihistamines |
JP5078869B2 (ja) * | 2005-03-08 | 2012-11-21 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | ニューロキニン(nk1)拮抗物質としてのジアザ−スピロ−[4.4]−ノナン誘導体 |
US7598261B2 (en) | 2005-03-31 | 2009-10-06 | Adolor Corporation | Spirocyclic heterocyclic derivatives and methods of their use |
CA2614963C (en) | 2005-07-19 | 2014-10-07 | Merck & Co., Inc. | Spirochromanone derivatives as acetyl coenzyme a carboxylase (acc) inhibitors |
US7576207B2 (en) | 2006-04-06 | 2009-08-18 | Adolor Corporation | Spirocyclic heterocyclic derivatives and methods of their use |
US20090186901A1 (en) * | 2006-05-05 | 2009-07-23 | Ulrich Reiser | Chemical compounds |
JP2010503669A (ja) * | 2006-09-12 | 2010-02-04 | アドラー コーポレーション | 認知機能の強化のためのn含有スピロ化合物の使用 |
WO2008088692A2 (en) | 2007-01-12 | 2008-07-24 | Merck & Co., Inc. | Spirochromanon derivatives |
PE20081559A1 (es) | 2007-01-12 | 2008-11-20 | Merck & Co Inc | DERIVADOS DE ESPIROCROMANONA SUSTITUIDOS COMO INHIBIDORES DE ACETIL CoA CARBOXILASA |
US9340558B2 (en) | 2007-11-02 | 2016-05-17 | Pain Therapeutics Inc. | Filamin a binding anti-inflammatory and analgesic |
US8653068B2 (en) | 2009-10-30 | 2014-02-18 | Pain Therapeutics, Inc. | Filamin A binding anti-inflammatory and analgesic |
US8614324B2 (en) * | 2008-10-31 | 2013-12-24 | Pain Therapeutics, Inc. | Filamin A binding anti-inflammatory and analgesic |
EP2265588B1 (de) * | 2008-02-27 | 2013-06-26 | Vitae Pharmaceuticals, Inc. | Inhibitoren von 11b-hydroxysteroiddehydrogenase von typ 1 |
CA2779252C (en) * | 2008-10-31 | 2015-05-05 | Pain Therapeutics, Inc. | Filamin a-binding anti-inflammatory analgesic |
US8580808B2 (en) * | 2009-10-30 | 2013-11-12 | Pain Therapeutic, Inc. | Filamin A-binding anti-inflammatory analgesic |
US8580809B2 (en) * | 2009-10-30 | 2013-11-12 | Pain Therapeutics, Inc. | Filamin A-binding anti-inflammatory analgesic |
ES2716049T3 (es) | 2012-07-13 | 2019-06-07 | Pain Therapeutics Inc | Un método para inhibir la fosforilación de tau |
US9433604B2 (en) | 2013-10-08 | 2016-09-06 | Pain Therapeutics Inc. | Method for inhibiting growth of cancer cells |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4166119A (en) * | 1978-04-14 | 1979-08-28 | American Hoechst Corporation | Analgesic and tranquilizing spiro[dihydrobenzofuran]piperidines and pyrrolidines |
US4166120A (en) * | 1978-04-14 | 1979-08-28 | American Hoechst Corporation | Analgesic and tranquilizing benzoylpropyl-spiro[dihydrobenzofuran]piperidines and pyrrolidines |
US4420485A (en) * | 1982-09-29 | 1983-12-13 | Hoechst-Roussel Pharmaceuticals Inc. | 1'-[3-(1,2-Benzisoxazol-3-yl) proply]spiro[benzofuran-2(3H),3' or 4'-piperidines or 3'-pyrrolidines] |
US4452802A (en) * | 1983-08-25 | 1984-06-05 | Hoechst-Roussel Pharmaceuticals Incorporated | Antihypertensive spiro[benzofuran-azalkanes] |
ES2074441T3 (es) * | 1987-10-05 | 1995-09-16 | Yamanouchi Pharma Co Ltd | Compuestos espiro heterociclicos y su preparacion. |
US5075317A (en) * | 1989-06-21 | 1991-12-24 | Fisons Corporation | Spirofurane derivatives |
IE903957A1 (en) * | 1989-11-06 | 1991-05-08 | Sanofi Sa | Aromatic amine compounds, their method of preparation and¹pharmaceutical compositions in which they are present |
IL96507A0 (en) * | 1989-12-08 | 1991-08-16 | Merck & Co Inc | Nitrogen-containing spirocycles and pharmaceutical compositions containing them |
EP0450761A1 (de) * | 1990-03-02 | 1991-10-09 | Merck & Co. Inc. | Spirocyclische Oxtocin-Antagonisten |
US5091387A (en) * | 1990-03-02 | 1992-02-25 | Merck & Co., Inc. | Spirocyclic oxytocin antagonists |
EP0445974A3 (en) * | 1990-03-05 | 1992-04-29 | Merck Sharp & Dohme Ltd. | Spirocyclic antipsychotic agents |
IL99320A (en) * | 1990-09-05 | 1995-07-31 | Sanofi Sa | Arylalkylamines, their preparation and pharmaceutical preparations containing them |
-
1994
- 1994-01-25 CA CA002154569A patent/CA2154569A1/en not_active Abandoned
- 1994-01-25 EP EP94907866A patent/EP0681571B1/de not_active Expired - Lifetime
- 1994-01-25 AU AU61268/94A patent/AU693087B2/en not_active Ceased
- 1994-01-25 DE DE69412067T patent/DE69412067T2/de not_active Expired - Fee Related
- 1994-01-25 JP JP6517241A patent/JPH08505880A/ja active Pending
- 1994-01-25 WO PCT/US1994/000819 patent/WO1994017045A1/en active IP Right Grant
- 1994-01-25 ES ES94907866T patent/ES2119174T3/es not_active Expired - Lifetime
- 1994-01-25 AT AT94907866T patent/ATE169001T1/de not_active IP Right Cessation
- 1994-01-25 DK DK94907866T patent/DK0681571T3/da active
- 1994-01-25 US US08/481,418 patent/US5869496A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP0681571A1 (de) | 1995-11-15 |
DE69412067T2 (de) | 1999-03-25 |
WO1994017045A1 (en) | 1994-08-04 |
US5869496A (en) | 1999-02-09 |
DE69412067D1 (de) | 1998-09-03 |
EP0681571B1 (de) | 1998-07-29 |
JPH08505880A (ja) | 1996-06-25 |
DK0681571T3 (da) | 1998-11-23 |
ES2119174T3 (es) | 1998-10-01 |
AU693087B2 (en) | 1998-06-25 |
AU6126894A (en) | 1994-08-15 |
CA2154569A1 (en) | 1994-08-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE169001T1 (de) | Substituierte spiro-azaringen als tachykinine rezeptor antagonisten | |
DE69528823D1 (en) | Morpholinwirkstoffvorläufer als tachykininreceptorantagonisten | |
DE69504300D1 (de) | Gem-bissubstituierte azazyclische tachykinin-antagonisten | |
DE69318854T2 (de) | Spiroazacyclischderivate als substanz p antagonisten | |
HK1008819A1 (en) | Piperidine derivatives as neurokinin antagonists | |
DE69327541D1 (en) | 4-arylmethyloxymethyl piperidine als tachykinin antagonisten | |
DE69331190T2 (de) | Überbrückte azabicyclische derivate als substanz p antagonisten | |
ES2160103T3 (es) | Peptidos que tienen actividad antagonista de taquiquinina. | |
DE59505853D1 (de) | Triazolverbindungen und deren verwendung als dopamin-d3-liganden | |
DE69735482D1 (de) | Spiro-azacyclische derivate, deren herstellung und verwendung als tachykinin-antagonisten | |
DE69626321T2 (de) | Substituierte 4-(1h-benzimidazol-2-yl-amino)piperidine zur behandlung allergischer erkrankungen | |
GB9603137D0 (en) | Therapeutic agents | |
DE69504198D1 (de) | Substituierte alkyldiaminderivate und ihre verwendung als tachykinin antagonisten |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
REN | Ceased due to non-payment of the annual fee |